Sanford-Burnham Medical Research Institute (Sanford-Burnham) has teamed up with pharma major Pfizer, to identify new therapeutic targets to prevent and treat obesity and diabetes complications. With plans to discover new treatments for ...
Tags: Sanford-Burnham, Pfizer
India has partly suspended patents granted to Roche Holding for its breast cancer drug Herceptin, over issues that the patents had not been filed in accordance with the laid down process. An article published in Swiss newspaper Schweiz am ...
Tags: Cancer Drug Patent
Pfizer’s Wyeth has consented to pay $491m in fine for unlawful marketing of its kidney drug Rapamune, an FDA-approved immunosuppressant drug used to prevent rejection in organ transplantation. In order to boost Rapamune sales, the ...
Tags: Pfizer Unit, Medicine
Pfizer has reported a net income attributable to the company of $14.09bn, or $1.98 per diluted share, for the second quarter of 2013 compared to $3.25bn, or $0.43 for the second quarter of 2012. Revenues for the second quarter of 2013 ...
Tags: Pfizer, Net Income
Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients. The three business ...
Tags: Pfizer, Commercial Businesses
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has confirmed its opinion for European marketing authorization of Pfizer's Xeljanz (tofacitinib citrate). Xeljanz is a novel, oral Janus kinase ...
Pfizer's rheumatoid arthritis treatment, tofacitinib, has obtained approval in several additional countries globally, including Switzerland, Argentina, Kuwait, UAE and Russia for patients with inadequate response to current therapies. The ...
The UK National Institute for Health and Care Excellence (NICE) has rejected Pfizer’s new chronic myeloid leukaemia (CML) drug, Bosulif (bosutinib). NICE chief executive Sir Andrew Dillon said there is evidence to suggest that ...
Tags: Cancer Drug, Medicine
Pfizer has obtained European approval for the expanded use of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), in adults between 18 to 49 years of age for the prevention of invasive pneumococcal disease. ...
Tags: Pneumococcal Vaccine, Medicine
The US FDA has accepted to review Bristol-Myers Squibb Company and Pfizer's Eliquis (apixaban) supplemental new drug application for prophylaxis of deep vein thrombosis (DVT) subsequent to hip or knee replacement surgery. The application ...
Tags: Drug Application, Medicine
A combination of GlaxoSmithKline’s GSK744 and J&J’s TMC278 monthly injection therapy, designed to evaluate its potential to control HIV, is currently being tested. Results of a study, which was conducted on 40 HIV-negative ...
Tags: Injection Therapy, Medicine
Teva Pharmaceutical Industries has introduced generic version of Pfizer's Viagra (sildenafil) in Germany, UK, Italy, the Netherlands, Switzerland, Ireland, Austria, Belgium and Denmark following patent expiry. Offered through the ...
Tags: Pfizer's Viagra, Viagra
The USFDA has accepted Pfizer's supplemental new drug application (sNDA) to expand labeling of rheumatoid arthritis medication Xeljanz (tofacitinib citrate) to include inhibition of structural damage progression. The data from ORAL Start ...
Tags: FDA, Pfizer sNDA, Xeljanz Labeling
Pfizer has reached a $2.15bn settlement with Teva Pharmaceuticals Industries, and Sun Pharmaceutical Industries over Protonix patent-infringement lawsuit in the US. Following 10-years of litigation over the intellectual property for ...
Tags: Pfizer, Sun Pharma
Specialty pharmaceutical company Sun Pharmaceutical Industries has obtained final USFDA approval for the abbreviated new drug application of generic Depo-Testosterone Injection, Testosterone Cypionate Injection USP, 100mg/ml and 200mg/ml. ...